GSK Settles Bulk of Avandia MDL Cases

GlaxoSmithKline has settled a majority of state cases and multidistrict litigation cases over its alleged failure to warn consumers about health risks related to diabetes drug Avandia, which has been linked to increased occurrences of heart attack and stroke, the company said.
Law360